Deciphering the interplay among multisite phosphorylation, interaction dynamics, and conformational transitions in a tripartite protein system

ACS Central Science

Volumn 2, Issue 7, 2016, Pages 445-455

  Lössl, Philip ^a,b   Brunner, Andrea M ^a,b   Liu, Fan ^a,b   Leney, Aneika C ^a,b   Yamashita, Masami ^c   Scheltema, Richard A ^a,b   Heck, Albert J R ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NETHERLANDS PROTEOMICS CENTRE   (Netherlands)

^c MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYMES; MASS SPECTROMETRY; MOLECULAR BIOLOGY;

BIOCHEMICAL ANALYSIS; BOTTOM-UP AND TOP-DOWN; CONFORMATIONAL TRANSITIONS; INTERACTION DYNAMICS; ION MOBILITY SPECTROMETRY; PHOSPHORYLATION REACTIONS; PROTEIN PHOSPHORYLATION; STRUCTURAL REARRANGEMENT;

PHOSPHORYLATION;

EID: 85010313292     PISSN: 23747943     EISSN: 23747951     Source Type: Journal    
DOI: 10.1021/acscentsci.6b00053     Document Type: Article

References (45)

1. Cohen, P. The regulation of protein function by multisite phosphorylation-A 25 year update. Trends Biochem. Sci. 2000, 25, 596-601.
2. Holmberg, C. I.; Tran, S. E. F.; Eriksson, J. E.; Sistonen, L. Multisite phosphorylation provides sophisticated regulation of transcription factors. Trends Biochem. Sci. 2002, 27, 619-627.
3. Bode, A. M.; Dong, Z. Post-translational modification of p53 in tumorigenesis. Nat. Rev. Cancer 2004, 4, 793-805.
4. Medina, M.; Avila, J. Further understanding of tau phosphorylation: Implications for therapy. Expert Rev. Neurother. 2015, 15, 115- 122.
5. Deshaies, R. J.; Ferrell, J. E. Multisite Phosphorylation and the Countdown to S Phase. Cell 2001, 107, 819-822.
6. Koivomägi, M.; Ord, M.; Iofik, A.; Valk, E.; Venta, R.; Faustova, I.; Kivi, R.; Balog, E. R. M.; Rubin, S. M.; Loog, M. Multisite phosphorylation networks as signal processors for Cdk1. Nat. Struct. Mol. Biol. 2013, 20, 1415-1424.
7. Verdugo, A.; Vinod, P. K.; Tyson, J. J.; Novak, B. Molecular mechanisms creating bistable switches at cell cycle transitions. Open Biol. 2013, 3, 120179.
8. Lapenna, S.; Giordano, A. Cell cycle kinases as therapeutic targets for cancer. Nat. Rev. Drug Discovery 2009, 8, 547-566.
9. Reindl, W.; Yuan, J.; Krämer, A.; Strebhardt, K.; Berg, T. Inhibition of polo-like kinase 1 by blocking polo-box domaindependent protein-protein interactions. Chem. Biol. 2008, 15, 459- 466.
10. Shagisultanova, E.; Dunbrack, R. L.; Golemis, E. A. Issues in interpreting the in vivo activity of Aurora-A. Expert Opin. Ther. Targets 2015, 19, 187-200.
11. Whittaker, S. R.; Walton, M. I.; Garrett, M. D.; Workman, P. The Cyclin-dependent kinase inhibitor CYC202 (R-roscovitine) inhibits retinoblastoma protein phosphorylation, causes loss of Cyclin D1, and activates the mitogen-activated protein kinase pathway. Cancer Res. 2004, 64, 262-272.
12. Nash, P.; Tang, X.; Orlicky, S.; Chen, Q.; Gertler, F. B.; Mendenhall, M. D.; Sicheri, F.; Pawson, T.; Tyers, M. Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication. Nature 2001, 414, 514-521.
13. Koivomägi, M.; Valk, E.; Venta, R.; Iofik, A.; Lepiku, M.; Balog, E. R. M.; Rubin, S. M.; Morgan, D. O.; Loog, M. Cascades of multisite phosphorylation control Sic1 destruction at the onset of S phase. Nature 2011, 480, 128-131.
14. Kim, S. Y.; Song, E. J.; Lee, K.-J.; Ferrell, J. E. Multisite M-phase phosphorylation of Xenopus Wee1A. Mol. Cell. Biol. 2005, 25, 10580- 10590.
15. Tak, Y.-S.; Tanaka, Y.; Endo, S.; Kamimura, Y.; Araki, H. A CDK-catalysed regulatory phosphorylation for formation of the DNA replication complex Sld2-Dpb11. EMBO J. 2006, 25, 1987-1996.
16. Bibow, S.; Ozenne, V.; Biernat, J.; Blackledge, M.; Mandelkow, E.; Zweckstetter, M. Structural impact of proline-directed pseudophosphorylation at AT8, AT100, and PHF1 epitopes on 441-residue tau. J. Am. Chem. Soc. 2011, 133, 15842-15845.
17. Okamura, H.; Aramburu, J.; García-Rodríguez, C.; Viola, J. P.; Raghavan, A.; Tahiliani, M.; Zhang, X.; Qin, J.; Hogan, P. G.; Rao, A. Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity. Mol. Cell 2000, 6, 539-550.
18. van de Waterbeemd, M. J.; Lössl, P.; Gautier, V.; Marino, F.; Yamashita, M.; Conti, E.; Scholten, A.; Heck, A. J. Simultaneous assessment of kinetic, site-specific, and structural aspects of enzymatic protein phosphorylation. Angew. Chem., Int. Ed. 2014, 53, 9660-9664.
19. Rose, R. J.; Damoc, E.; Denisov, E.; Makarov, A.; Heck, A. J. High-sensitivity Orbitrap mass analysis of intact macromolecular assemblies. Nat. Methods 2012, 9, 1084-1086.
20. Snijder, J.; van de Waterbeemd, M.; Damoc, E.; Denisov, E.; Grinfeld, D.; Bennett, A.; Agbandje-McKenna, M.; Makarov, A.; Heck, A. J. Defining the stoichiometry and cargo load of viral and bacterial nanoparticles by Orbitrap mass spectrometry. J. Am. Chem. Soc. 2014, 136, 7295-7299.
21. Sinz, A. The advancement of chemical cross-linking and mass spectrometry for structural proteomics: From single proteins to protein interaction networks. Expert Rev. Proteomics 2014, 11, 733-743.
22. Schmidt, C.; Zhou, M.; Marriott, H.; Morgner, N.; Politis, A.; Robinson, C. V. Comparative cross-linking and mass spectrometry of an intact F-type ATPase suggest a role for phosphorylation. Nat. Commun. 2013, 4, 1985.
23. Compton, P. D.; Zamdborg, L.; Thomas, P. M.; Kelleher, N. L. On the scalability and requirements of whole protein mass spectrometry. Anal. Chem. 2011, 83, 6868-6874.
24. Brunner, A. M.; Lössl, P.; Liu, F.; Huguet, R.; Mullen, C.; Yamashita, M.; Zabrouskov, V.; Makarov, A.; Altelaar, A. F.; Heck, A. J. Benchmarking multiple fragmentation methods on an orbitrap fusion for top-down phospho-proteoform characterization. Anal. Chem. 2015, 87, 4152-4158.
25. Pan, J.; Zhang, S.; Borchers, C. H. Protein species-specific characterization of conformational change induced by multisite phosphorylation. J. Proteomics 2016, 134, 138-143.
26. Yu, D.; Peng, Y.; Ayaz-Guner, S.; Gregorich, Z. R.; Ge, Y. Comprehensive Characterization of AMP-Activated Protein Kinase Catalytic Domain by Top-Down Mass Spectrometry. J. Am. Soc. Mass Spectrom. 2016, 27, 220-232.
27. Lanucara, F.; Holman, S. W.; Gray, C. J.; Eyers, C. E. The power of ion mobility-mass spectrometry for structural characterization and the study of conformational dynamics. Nat. Chem. 2014, 6, 281-294.
28. Wojnowska, M.; Yan, J.; Sivalingam, G. N.; Cryar, A.; Gor, J.; Thalassinos, K.; Djordjevic, S. Autophosphorylation activity of a soluble hexameric histidine kinase correlates with the shift in protein conformational equilibrium. Chem. Biol. 2013, 20, 1411-1420.
29. Uetrecht, C.; Rose, R. J.; van Duijn, E.; Lorenzen, K.; Heck, A. J. Ion mobility mass spectrometry of proteins and protein assemblies. Chem. Soc. Rev. 2010, 39, 1633-1655.
30. Bruinsma, W.; Macurek, L.; Freire, R.; Lindqvist, A.; Medema, R. H. Bora and Aurora-A continue to activate Plk1 in mitosis. J. Cell Sci. 2014, 127, 801-811.
31. Chan, E. H. Y.; Santamaria, A.; Silljé, H. H. W.; Nigg, E. A. Plk1 regulates mitotic Aurora A function through ßTrCP-dependent degradation of hBora. Chromosoma 2008, 117, 457-469.
32. Macu°rek, L.; Lindqvist, A.; Lim, D.; Lampson, M. A.; Klompmaker, R.; Freire, R.; Clouin, C.; Taylor, S. S.; Yaffe, M. B.; Medema, R. H. Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery. Nature 2008, 455, 119-123.
33. Seki, A.; Coppinger, J. A.; Jang, C.-Y.; Yates, J. R.; Fang, G. Bora and the Kinase Aurora A Cooperatively Activate the Kinase Plk1 and Control Mitotic Entry. Science 2008, 320, 1655-1658.
34. Feine, O.; Hukasova, E.; Bruinsma, W.; Freire, R.; Fainsod, A.; Gannon, J.; Mahbubani, H. M.; Lindqvist, A.; Brandeis, M. Phosphorylation-mediated stabilization of Bora in mitosis coordinates Plx1/Plk1 and Cdk1 oscillations. Cell Cycle 2014, 13, 1727-1736.
35. Lee, Y.-C.; Liao, P.-C.; Liou, Y.-C.; Hsiao, M.; Huang, C.-Y.; Lu, P.-J. Glycogen synthase kinase 3 ß activity is required for hBora/ Aurora A-mediated mitotic entry. Cell Cycle 2013, 12, 953-960.
36. Tavernier, N.; Noatynska, A.; Panbianco, C.; Martino, L.; van Hove, L.; Schwager, F.; Léger, T.; Gotta, M.; Pintard, L. Cdk1 phosphorylates SPAT-1/Bora to trigger PLK-1 activation and drive mitotic entry in C. elegans embryos. J. Cell Biol. 2015, 208, 661-669.
37. Hutterer, A.; Berdnik, D.; Wirtz-Peitz, F.; Z?igman, M.; Schleiffer, A.; Knoblich, J. A. Mitotic Activation of the Kinase Aurora-A Requires Its Binding Partner Bora. Dev. Cell 2006, 11, 147- 157.
38. Seki, A.; Coppinger, J. A.; Du, H.; Jang, C.-Y.; Yates, J. R.; Fang, G. Plk1- and -TrCP-dependent degradation of Bora controls mitotic progression. J. Cell Biol. 2008, 181, 65-78.
39. Bayliss, R.; Sardon, T.; Vernos, I.; Conti, E. Structural basis of Aurora-A activation by TPX2 at the mitotic spindle. Mol. Cell 2003, 12, 851-862.
40. Lee, C.-R.; Park, Y.-H.; Kim, Y.-R.; Peterkofsky, A.; Seok, Y.-J. Phosphorylation-Dependent Mobility Shift of Proteins on SDS-PAGE is Due to Decreased Binding of SDS. Bull. Korean Chem. Soc. 2013, 34, 2063-2066.
41. Lindqvist, A.; Rodríguez-Bravo, V.; Medema, R. H. The decision to enter mitosis: Feedback and redundancy in the mitotic entry network. J. Cell Biol. 2009, 185, 193-202.
42. Xu, J.; Shen, C.; Wang, T.; Quan, J. Structural basis for the inhibition of Polo-like kinase 1. Nat. Struct. Mol. Biol. 2013, 20, 1047- 1053.
43. Merkley, E. D.; Rysavy, S.; Kahraman, A.; Hafen, R. P.; Daggett, V.; Adkins, J. N. Distance restraints from crosslinking mass spectrometry: Mining a molecular dynamics simulation database to evaluate lysine-lysine distances. Protein Sci. 2014, 23, 747-759.
44. Dang, X.; Scotcher, J.; Wu, S.; Chu, R. K.; Tolić, N.; Ntai, I.; Thomas, P. M.; Fellers, R. T.; Early, B. P.; Zheng, Y.; Durbin, K. R.; Leduc, R. D.; Wolff, J. J.; Thompson, C. J.; Pan, J.; Han, J.; Shaw, J. B.; Salisbury, J. P.; Easterling, M.; Borchers, C. H.; Brodbelt, J. S.; Agar, J. N.; Pas?a-Tolić, L.; Kelleher, N. L.; Young, N. L. The first pilot project of the consortium for top-down proteomics: A status report. Proteomics 2014, 14, 1130-1140.
45. Zheng, Y.; Fornelli, L.; Compton, P. D.; Sharma, S.; Canterbury, J.; Mullen, C.; Zabrouskov, V.; Fellers, R. T.; Thomas, P. M.; Licht, J. D.; Senko, M. W.; Kelleher, N. L. Unabridged Analysis of Human Histone H3 by Differential Top-Down Mass Spectrometry Reveals Hypermethylated Proteoforms from MMSET/NSD2 Overexpression. Mol. Cell. Proteomics 2016, 15, 776-790.